The Latest Guidance on IBS-C Pharmacological Management: The Lead Author’s Perspective
Lin Chang, MD, AGAF spoke with Physician’s Weekly about the guideline and the overall topic of pharmacological management of IBS-C.
Nov 2, 2023
PEER-TO-PEER 
Peer-to-Peer: IBS-C
Physician’s Weekly-created content featuring key opinion leaders sharing their perspectives on IBS-C from different vantage points.
Innovative & Insightful IBS-C Peer to Peer eBook
Innovative & Insightful IBS-C Peer to Peer eBook
An innovative, curated ebook featuring insightful IBS-C findings and input from key opinion leaders in the field of gastroenterology.
NHE3 Inhibitors for IBS-C: A Primary Care Physician’s Perspective
NHE3 Inhibitors for IBS-C: A Primary Care Physician’s Perspective
Physician’s Weekly recently spoke with Linda Girgis, MD, FAAFP, about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.
NHE3 Inhibitors for IBS-C: A Study Author’s Perspective
NHE3 Inhibitors for IBS-C: A Study Author’s Perspective
Physician’s Weekly recently spoke with William D. Chey, MD, FACG, AGAF, FACP, RFF, lead author of the phase 3 T3MPO-2 study—which assessed the efficacy of the NHE3 inhibitor tenapanor in treating patients with irritable bowel syndrome with constipation (IBS-C)—about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.
NHE3 Inhibitors for IBS-C: A Guideline Author’s Perspective
NHE3 Inhibitors for IBS-C: A Guideline Author’s Perspective
Physician’s Weekly recently spoke with Lin Chang, MD, AGAF, lead author of the 2022 AGA Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation (IBS-C).
NHE3 Inhibitors for IBS-C: A Texas Gastroenterologist’s Perspective
NHE3 Inhibitors for IBS-C: A Texas Gastroenterologist’s Perspective
Physician’s Weekly recently spoke with Brooks Cash, MD about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.
NHE3 Inhibitors for IBS-C: A Georgia Gastroenterologist’s Perspective
NHE3 Inhibitors for IBS-C: A Georgia Gastroenterologist’s Perspective
Physician’s Weekly recently spoke with Satish SC Rao, MD, PhD, FRCP, FACG, AGAF about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.
The Phase 3 T3MPO-2 Study: The Lead Author’s Perspective
The Phase 3 T3MPO-2 Study: The Lead Author’s Perspective
Physician’s Weekly recently spoke with William D. Chey, MD, FACG, AGAF, FACP, RFF, the lead...
The Phase 3 T3MPO-2 Study: A Gastroenterologist’s Perspective
The Phase 3 T3MPO-2 Study: A Gastroenterologist’s Perspective
Physician’s Weekly recently spoke with Brian E. Lacy, MD, PhD, a board-certified...
Advertisement
PW QUIZ
Advertisement
Stay connected to the latest news from Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
